Latest / Clinical Guideline InSights
AAN/AHS Pharmacologic Treatment for Migraine Prevention in Adults 2026 Guideline
The 2026 Pharmacologic Treatment for Migraine Prevention in Adults guideline, highlighting key recommendations across assessment of treatment efficacy, treatment of patients with or without comorbidities, assessment of adverse effects, and more.
Pharmacologic Treatment for Migraine Prevention in Adults
American Academy of Neurology/American Headache Society
August 31, 2026
Guideline Summary: https://www.guidelinecentral.com/guideline/5236152/
Full-Text: https://www.neurology.org/doi/10.1212/WNL.0000000000214881
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.